Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Gross Profit (2024 - 2025)

Beta Bionics (BBNX) has disclosed Gross Profit for 2 consecutive years, with $18.9 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 62.07% to $18.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $55.5 million through Dec 2025, up 54.75% year-over-year, with the annual reading at $55.5 million for FY2025, 54.75% up from the prior year.
  • Gross Profit hit $18.9 million in Q4 2025 for Beta Bionics, up from $15.1 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $18.9 million in Q4 2025 to a low of $7.2 million in Q1 2024.